Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report

Author： Xanthinaki Arsinoi  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.16, Iss.9, 2008-09, pp. : 1025-1033

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection

By Nicolatou-Galitis O.   Sotiropoulou-Lontou A.   Velegraki A.   Pissakas G.   Kolitsi G.   Kyprianou K.   Kouloulias V.   Papanikolaou I.   Yiotakis I.   Dardoufas K.  

Oral Oncology, Vol. 39, Iss. 4, 2003-06 ,pp. : 397-401

Elsevier

Access to resources Recommend Favorite

A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study

By Zenda Sadamoto  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 350-355

Springer Publishing Company

Access to resources Recommend Favorite

Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 381-386

Science Publishers

Access to resources Recommend Favorite

Radiotherapy for head and neck cancer in elderly patients

By Schofield C.P.   Sykes A.J.   Slevin N.J.   Rashid N.Z.Z.  

Radiotherapy and Oncology, Vol. 69, Iss. 1, 2003-10 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite

Oral Complications of Radiotherapy in Head and Neck Cancer: Strategies for Prevention and Management

By Cai Grau   Christian N. Andreassen   Kenneth Jensen   Jacob C. Lindegaard  

American Journal of Cancer, Vol. 3, Iss. 5, 2004-01 ,pp. : 291-298

Adis International

Access to resources Recommend Favorite